|
|
 |
The ResQPOD's selective
inspiratory
technology for
patients receiving
assisted
ventilation, for
example, during the
release phase of
CPR.
|
- Utilizes the
relationship of
the respiratory
and circulatory
systems.
- Selectively
impedes inspiratory
gases from
coming into the
lungs for
patients
receiving
assisted
ventilation, for
example, during
the release
phase of CPR.
- Results in
increasing
negative
pressure and
creating a
greater vacuum
in the chest,
and
- Results in
greater venous
return.
|
|
Increasing Blood
Flow During Assisted
Ventilation |
During the
decompression
(release) phase of
CPR, for example, an increase in
negative pressure in
the thoracic cavity
results in drawing
more blood back into
the chest, providing
greater venous
return to the heart.
|
|
CPR
Alone |
|
ResQPOD +
CPR |
 |
|
Blood Flow
to Heart |
|
Greater
Blood Flow
to Heart |
|
RELEASE: CPR
alone
delivers
approximately
15% of
normal blood
flow to the
heart |
|
RELEASE:
ResQPOD
doubles
blood flow
back to the
heart |
|
| |
|
Improved venous
return results in
increased cardiac
output during the
subsequent
compression phase of
CPR, providing
greater blood flow
to the brain. |
|
|
CPR
Alone |
|
ResQPOD +
CPR |
 |
|
Blood Flow
to Brain |
|
Greater
Blood Flow
to Brain |
|
COMPRESSION:
CPR alone
delivers
approximately
25% of
normal blood
flow to the
brain |
|
COMPRESSION:
ResQPOD
delivers
>70% of
normal blood
flow to the
brain |
|
The
ResQPOD
selectively
impedes
inspiratory
gases during
the release
phase of CPR
resulting
in:
-
Increased
negative
pressure
in the
thorax
-
Greater
venous
return
to the
heart
-
Increased
coronary
perfusion
-
Increased
blood
flow
during
the next
compression
|
|
